NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/09/2024
Voltar para busca
Dado oficial do USPTO
CAIDYA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
26
Atualização mais recente
24/09/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42, 45
Data de depósito
03/08/2022
Data de registro
24/09/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/09/2024
Última transação
24/09/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
03/10/2022
Primeiro uso no comércio
03/10/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Morrisville, NC
Examinador
GANDARA, KEYLA
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Clinipace, Inc.
Representantes
Margarita Wallach, Esq. MCCARTER & ENGLISH, LLP
Classificação técnica
Classes Nice
Classe 35Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of pharmaceuticalmedicalhealthcarelife sciences companies to assist them with clinical researchclinical trials and applications for drugbiologic and device approval; providing independent review of clinical trials for business purposes; Contract research organization (CRO) servicesbusiness management in the field of clinical trialsclinical data management
Classe 42
Contract research organization (CRO) servicesmonitoring of clinical trials for drugsbiologics and devices of pharmaceuticalmedicalhealthcarelife sciences companies for quality control purposesclinical trial project management in the nature of design and implementation of clinical trials and quality assurance for all major therapeutic areasin particular gastroenterologynephrologyurologyoncology; consulting services in the field of scientific research in the nature of conducting clinical trials in the pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsbiologics and medical devices; Software as a service (SaaS) services featuring software for accessingcollectingmanagingtrackinganalyzingreporting data and information on clinical trials; Contract research organization (CRO) servicescustom technical writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports; Contract research organization (CRO) servicescustom writing for others for non-advertising purposes in the nature of medical writing of clinical study protocols and reports for submission to regulatory authorities
Classe 45
Providing independent review of clinical trials involving human subjectsreviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research; regulatory compliance consulting in the pharmaceuticalmedicalhealthcarelife sciences fields
Publicações
Histórico de despachos e eventos da marca no USPTO.
26 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/09/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
17/08/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
17/08/2024
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/08/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/08/2024
IUAF
USE AMENDMENT FILED
12/06/2024
EISU
TEAS STATEMENT OF USE RECEIVED
12/06/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/12/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/10/2023
PUBO
PUBLISHED FOR OPPOSITION
17/10/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
27/09/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/09/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
07/09/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
07/09/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
07/09/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
07/09/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/09/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2023
GNRT
NON-FINAL ACTION E-MAILED
01/06/2023
CNRT
NON-FINAL ACTION WRITTEN
01/06/2023
DOCK
ASSIGNED TO EXAMINER
19/05/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/08/2022
NWAP
NEW APPLICATION ENTERED
06/08/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CAIDYA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.